Fate Therapeutics's chart data is dated 2026-10-09. There is no active technical signal. There are 2 published signal records.
Fate Therapeutics last closed at $2.18 (+2.35%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -2.0×. Its overall grade ranks 420 of 738 stocks in Healthcare.
About this company
Fate Therapeutics last closed at $2.18 (+2.35%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 420/738
Valuation grade C+
Related stocks
- PfizerCompetitor
세포치료·면역질환 파이프라인에서 대형 제약사 경쟁자
- Bristol-Myers SquibbCompetitor
세포치료 및 면역항암 분야에서 경쟁하는 글로벌 제약사
- NovartisCompetitor
CAR-T 등 세포치료 플랫폼 보유한 주요 경쟁사
About Fate Therapeutics
- What technical signals does Fate Therapeutics (FATE) have?
- Fate Therapeutics current technical signals: no active technical signal.
- Is Fate Therapeutics a cup-and-handle pattern?
- No. Fate Therapeutics has no valid Cup signal right now.
- What published figures are available for Fate Therapeutics?
- Market cap: $251.47M. Trailing 12 months PER: -2.0×. Latest quarter PBR: 1.67×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Fate Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.